Clinical Trial Update: Extracorporeal Immune Support System (EISS) for the Treatment of Septic Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicating completion of Phase 1 and Phase 2 studies of the Extracorporeal Immune Support System (EISS) for patients with severe sepsis an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Extracorporeal Immune Support System (EISS)

Snippet

Sponsor: University of Rostock | Conditions: Severe Sepsis and Septic Shock | Phase 1, Phase 2 | Status: COMPLETED